DEFA14AThe Ballot
LIGAND PHARMACEUTICALS INC files DEFA14A
Filed May 18, 2026 · 1mo ago · Accession 0001193125-26-228006
Plain English
This supplemental filing (DEFA14A) announces an amendment to the previously disclosed merger agreement between Ligand Pharmaceuticals Incorporated and XOMA Royalty Corporation. The amendment, dated May 16, 2026, adds XOMA Royalty Holdings Corporation ("HoldCo") as a party to the merger agreement.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- DEFA14A
- Filing date
- May 18, 2026
- Report date
- —
- Document
- d86489ddefa14a.htm
- Size
- 46 KB